The emerging role of contrast-enhanced mammography
- PMID: 31929976
- PMCID: PMC6942965
- DOI: 10.21037/qims.2019.11.09
The emerging role of contrast-enhanced mammography
Conflict of interest statement
Conflicts of Interest: S Schiaffino declares to be member of speakers’ bureau for General Electric. F Sardanelli declares to have received grants from or to be member of speakers’ bureau/advisory board for Bayer, Bracco, and General Electric. A Cozzi has no conflicts of interest to declare.
Comment on
-
Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer.Radiology. 2019 Oct;293(1):81-88. doi: 10.1148/radiol.2019182660. Epub 2019 Aug 27. Radiology. 2019. PMID: 31453765 Free PMC article.
References
-
- Sardanelli F, Aase HS, Álvarez M, Azavedo E, Baarslag HJ, Balleyguier C, Baltzer PA, Beslagic V, Bick U, Bogdanovic-Stojanovic D, Briediene R, Brkljacic B, Camps Herrero J, Colin C, Cornford E, Danes J, de Geer G, Esen G, Evans A, Fuchsjaeger MH, Gilbert FJ, Graf O, Hargaden G, Helbich TH, Heywang-Köbrunner SH, Ivanov V, Jónsson Á, Kuhl CK, Lisencu EC, Luczynska E, Mann RM, Marques JC, Martincich L, Mortier M, Müller-Schimpfle M, Ormandi K, Panizza P, Pediconi F, Pijnappel RM, Pinker K, Rissanen T, Rotaru N, Saguatti G, Sella T, Slobodníková J, Talk M, Taourel P, Trimboli RM, Vejborg I, Vourtsis A, Forrai G. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. Eur Radiol 2017;27:2737-43. 10.1007/s00330-016-4612-z - DOI - PMC - PubMed
-
- van Breest Smallenburg V, Nederend J, Voogd AC, Coebergh JWW, van Beek M, Jansen FH, Louwman WJ, Duijm LEM. Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands. Br J Cancer 2013;109:242-8. 10.1038/bjc.2013.253 - DOI - PMC - PubMed